20 May 2013
Keywords: Alcon, ESBATech, mergers and acquisitions, ophthalmology
Article | 14 September 2009
Switzerland’s Alcon has entered into a definitive agreement to acquire ESBATech AG, a Swiss biotechnology company. Alcon will pay ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 September 2009
© 2013 thepharmaletter.com